Core inding factor (CBF) leukemia subtypes, which includes leukemias harboring fusion genes CBFB/MYH11 or RUNX1/RUNX1T1, are associated with younger age and range from 20% in pediatric to less than 5% in older AML patients [309]. Here, RUNX1 is linked to leukemia.